Novel anti-inflammatory drug shows early promise in treating Long COVID cognitive symptoms, fatigue, PEM. The study looked at multiple endpoints and consulted with people living with the disease.

This summer’s COVID-19 wave is still lingering into the fall, as much of the country reports ongoing moderate to high disease ...

Changing seasons affect many people with Long COVID, myalgic encephalomyelitis, and other chronic illnesses, but not all in the same way. Research has a long way to go before it can explain the ...

Novel drug bezisterim plans for further study in Long COVID. Here’s how the phase 2 trial came together.Britta Shoot ...

Advocates, clinicians, and researchers must prioritize prevention and demonstrate the gravity of infection-associated chronic conditions like Long COVID by providing and wearing masks at public events ...

Changing seasons affect many people with Long COVID, myalgic encephalomyelitis, and other chronic illnesses, but not all in the same way. Research has a long way to go before it can explain the ...

Moderate to high levels of COVID-19 spread persist through much of the U.S., as of mid-October. Different data sources offer conflicting information about where cases may be increasing and decreasing.

Moderate to high levels of COVID-19 spread persist through much of the U.S., as of mid-October. Different data sources offer conflicting information about where cases may be increasing and decreasing.

Changing seasons affect many people with Long COVID, myalgic encephalomyelitis, and other chronic illnesses, but not all in the same way. Research has a long way to go before it can explain the ...

A large Long COVID review found mechanisms of “accelerated biological aging” in young adults. The review was published in Ageing Research Reviews and synthesized 110 mechanistic and epidemiological ...